144 related articles for article (PubMed ID: 27887643)
1. Distribution of FDG-avid nodes in esophageal cancer: implications for radiotherapy target delineation.
Garcia B; Goodman KA; Cambridge L; Dunphy M; Wu AJ
Radiat Oncol; 2016 Nov; 11(1):156. PubMed ID: 27887643
[TBL] [Abstract][Full Text] [Related]
2. Impact of
Münch S; Marr L; Feuerecker B; Dapper H; Braren R; Combs SE; Duma MN
Strahlenther Onkol; 2020 Sep; 196(9):787-794. PubMed ID: 32430661
[TBL] [Abstract][Full Text] [Related]
3. Distribution of lymph node metastases on FDG-PET/CT in inoperable or unresectable oesophageal cancer patients and the impact on target volume definition in radiation therapy.
Machiels M; Wouterse SJ; Geijsen ED; van Os RM; Bennink RJ; van Laarhoven HW; Hulshof MC
J Med Imaging Radiat Oncol; 2016 Aug; 60(4):520-7. PubMed ID: 27197751
[TBL] [Abstract][Full Text] [Related]
4. Does [18F] fluorodeoxyglucose-positron emission tomography/computed tomography have a role in cervical nodal staging for esophageal squamous cell carcinoma?
Li B; Li N; Liu S; Li Y; Qian B; Zhang Y; He H; Chen X; Sun Y; Xiang J; Hu H; Chen H
J Thorac Cardiovasc Surg; 2020 Aug; 160(2):544-550. PubMed ID: 31932053
[TBL] [Abstract][Full Text] [Related]
5. Understanding the pattern of lymph node metastasis for trans-segmental thoracic esophageal cancer to develop precise delineation of clinical target volume for radiotherapy.
Huang L; Chen C; Lin M; Li J
Ann Palliat Med; 2020 May; 9(3):788-794. PubMed ID: 32389008
[TBL] [Abstract][Full Text] [Related]
6. Identification of risk factors and the pattern of lower cervical lymph node metastasis in esophageal cancer: implications for radiotherapy target delineation.
Luo Y; Wang X; Liu Y; Wang C; Huang Y; Yu J; Li M
Oncotarget; 2017 Jun; 8(26):43389-43396. PubMed ID: 28118614
[TBL] [Abstract][Full Text] [Related]
7. Patterns of nodal metastases on 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma are useful to guide treatment planning of radiotherapy.
Liu CJ; Cheng JC; Lee JM; Cheng MF; Tzen KY; Yen RF
Clin Nucl Med; 2015 May; 40(5):384-9. PubMed ID: 25674870
[TBL] [Abstract][Full Text] [Related]
8. Significance of baseline FDG-PET/CT scan as a method of staging regional lymph nodes in patients with operable distal oesophageal or gastroesophageal junction adenocarcinoma.
Papaxoinis G; Weaver JMJ; Khoja L; Patrao A; Stamatopoulou S; Alchawaf A; Owen-Holt V; Germetaki T; Kordatou Z; Mansoor W
Acta Oncol; 2017 Sep; 56(9):1224-1232. PubMed ID: 28524708
[TBL] [Abstract][Full Text] [Related]
9. [FDG PET/CT versus PET alone for pre-surgical detection of lymph node metastasis in esophageal carcinoma].
Yuan SH; Yu JM; Yu YH; Fu Z; Guo HB; Liu TH; Yang XH; Yang GR; Li WW
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):221-4. PubMed ID: 17649642
[TBL] [Abstract][Full Text] [Related]
10. Using
Ma CL; Li XD; Sun XR; Zhao DB; Yuan YP; Yu YH
J Cancer Res Ther; 2018; 14(4):896-901. PubMed ID: 29970673
[TBL] [Abstract][Full Text] [Related]
11. Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer.
Fasmer KE; Gulati A; Dybvik JA; Ytre-Hauge S; Salvesen Ø; Trovik J; Krakstad C; Haldorsen IS
Eur Radiol; 2020 May; 30(5):2443-2453. PubMed ID: 32034487
[TBL] [Abstract][Full Text] [Related]
12. Nodal FDG-PET/CT uptake influences outcome and relapse location among esophageal cancer patients submitted to chemotherapy or radiochemotherapy.
Jimenez-Jimenez E; Mateos P; Ortiz I; Aymar N; Roncero R; Gimenez M; Pardo J; Sabater S
Clin Transl Oncol; 2019 Sep; 21(9):1159-1167. PubMed ID: 30661172
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of [
Feldman HA; Erasmus JJ; Zhou N; Antonoff MB; Mehran RJ; Rajaram R; Rice DC; Sepesi B; Swisher SG; Vaporciyan AA; Walsh GL; Hofstetter WL; Betancourt Cuellar SL
Ann Thorac Surg; 2022 Oct; 114(4):1183-1188. PubMed ID: 34634240
[TBL] [Abstract][Full Text] [Related]
14. Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?
Vrieze O; Haustermans K; De Wever W; Lerut T; Van Cutsem E; Ectors N; Hiele M; Flamen P
Radiother Oncol; 2004 Dec; 73(3):269-75. PubMed ID: 15588870
[TBL] [Abstract][Full Text] [Related]
15. FDG-PET/CT lymph node staging after neoadjuvant chemotherapy in patients with adenocarcinoma of the esophageal-gastric junction.
Fencl P; Belohlavek O; Harustiak T; Zemanova M
Abdom Radiol (NY); 2016 Nov; 41(11):2089-2094. PubMed ID: 27405645
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Value of
Voskuilen CS; Schweitzer D; Jensen JB; Nielsen AM; Joniau S; Muilwijk T; Necchi A; Azizi M; Spiess PE; Briganti A; Bandini M; Goffin K; Bouchelouche K; van Werkhoven E; Shariat SF; Xylinas E; Azawi NH; Ku JH; Foerster B; van Rhijn BWG; Vegt E; Hendricksen K
Eur Urol Oncol; 2020 Feb; 3(1):73-79. PubMed ID: 31591037
[TBL] [Abstract][Full Text] [Related]
17. Can hybrid FDG-PET/CT detect subclinical lymph node metastasis of esophageal cancer appropriately and contribute to radiation treatment planning? A comparison of image-based and pathological findings.
Shimizu S; Hosokawa M; Itoh K; Fujita M; Takahashi H; Shirato H
Int J Clin Oncol; 2009 Oct; 14(5):421-5. PubMed ID: 19856050
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma.
Liu DD; Li J; Li X; Xie L; Qin L; Peng F; Cheng MH
J Gynecol Oncol; 2019 Nov; 30(6):e89. PubMed ID: 31576685
[TBL] [Abstract][Full Text] [Related]
19. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy.
Lerut T; Flamen P; Ectors N; Van Cutsem E; Peeters M; Hiele M; De Wever W; Coosemans W; Decker G; De Leyn P; Deneffe G; Van Raemdonck D; Mortelmans L
Ann Surg; 2000 Dec; 232(6):743-52. PubMed ID: 11088069
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcinoma of the esophagogastric junction: the pattern of metastatic lymph node dissemination as a rationale for elective lymphatic target volume definition.
Meier I; Merkel S; Papadopoulos T; Sauer R; Hohenberger W; Brunner TB
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1408-17. PubMed ID: 18374226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
